BCLI BRAINSTORM CELL THERAPEUTICS INC Investments/Divestments 8-K Filing 2024 - Securities Purchase Agreement Brainstorm Cell Therapeutics Inc. entered into a Securities Purchase Agreement to sell registered shares of common stock, pre-funded warrants, and unregistered warrants, yielding gross proceeds of approximately $4.0 million.Get access to all SEC 8-K filings of the BRAINSTORM CELL THERAPEUTICS INC